SRVR vs. GNOM
SRVR (Pacer Data & Infrastructure Real Estate ETF) and GNOM (Global X Genomics & Biotechnology ETF) are both exchange-traded funds - SRVR is a REIT fund tracking the FTSE Nareit All Equity REITs Index, while GNOM is a Health & Biotech Equities fund tracking the Solactive Genomics Index. Both are passively managed. Over the past 5 years, SRVR returned -3.67%/yr vs -9.25%/yr for GNOM. At a 0.48 correlation, their price movements are largely independent. SRVR charges 0.49%/yr vs 0.50%/yr for GNOM.
Performance
SRVR vs. GNOM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SRVR achieves a 6.87% return, which is significantly lower than GNOM's 21.35% return.
SRVR
- 1D
- -1.78%
- 1M
- -10.64%
- 6M
- 0.07%
- YTD
- 6.87%
- 1Y
- -4.54%
- 3Y*
- 3.89%
- 5Y*
- -3.67%
- 10Y*
- —
GNOM
- 1D
- -1.59%
- 1M
- 10.30%
- 6M
- 15.28%
- YTD
- 21.35%
- 1Y
- 60.82%
- 3Y*
- 4.39%
- 5Y*
- -9.25%
- 10Y*
- —
SRVR vs. GNOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
SRVR Pacer Data & Infrastructure Real Estate ETF | 6.87% | -1.99% | 2.70% | 6.84% | -31.90% | 22.31% | 11.99% | 15.27% |
GNOM Global X Genomics & Biotechnology ETF | 21.35% | 18.65% | -15.99% | -8.63% | -36.27% | -15.93% | 51.52% | 2.03% |
Correlation
The correlation between SRVR and GNOM is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.45 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2019 | 0.48 |
The correlation between SRVR and GNOM has been stable across timeframes, ranging from 0.42 to 0.51 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SRVR vs. GNOM — Risk / Return Rank
SRVR
GNOM
SRVR vs. GNOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacer Data & Infrastructure Real Estate ETF (SRVR) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRVR | GNOM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.50 | ||
| Sortino ratioReturn per unit of downside risk | -3.31 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.35 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | -0.30 | 3.36 | -3.67 |
| Martin ratioReturn relative to average drawdown | -0.60 | 9.64 | -10.24 |
Loading charts...
Drawdowns
SRVR vs. GNOM - Drawdown Comparison
The maximum SRVR drawdown since its inception was -40.99%, smaller than the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for SRVR and GNOM.
Loading charts...
Drawdown Indicators
| SRVR | GNOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.99% | -75.00% | +34.01% |
Max Drawdown (1Y)Largest decline over 1 year | -14.98% | -18.17% | +3.19% |
Max Drawdown (3Y)Largest decline over 3 years | -18.34% | -44.24% | +25.90% |
Max Drawdown (5Y)Largest decline over 5 years | -40.99% | -72.14% | +31.15% |
Current DrawdownCurrent decline from peak | -21.75% | -49.85% | +28.10% |
Average DrawdownAverage peak-to-trough decline | -15.27% | -40.70% | +25.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.55% | 6.33% | +1.22% |
Volatility
SRVR vs. GNOM - Volatility Comparison
The current volatility for Pacer Data & Infrastructure Real Estate ETF (SRVR) is 4.22%, while Global X Genomics & Biotechnology ETF (GNOM) has a volatility of 7.69%. This indicates that SRVR experiences smaller price fluctuations and is considered to be less risky than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SRVR | GNOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.22% | 7.69% | -3.47% |
Volatility (6M)Calculated over the trailing 6-month period | 14.02% | 20.75% | -6.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.29% | 27.34% | -10.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.85% | 33.71% | -13.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.41% | 34.12% | -12.71% |
SRVR vs. GNOM - Expense Ratio Comparison
SRVR has a 0.49% expense ratio, which is lower than GNOM's 0.50% expense ratio.
Dividends
SRVR vs. GNOM - Dividend Comparison
SRVR's dividend yield for the trailing twelve months is around 2.86%, more than GNOM's 1.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 1.18% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% | 0.00% | 0.00% |
SRVR Pacer Data & Infrastructure Real Estate ETF | 2.86% | 2.67% | 2.00% | 3.69% | 1.70% | 1.19% | 1.59% | 1.61% | 2.13% |
Frequently Asked Questions
SRVR and GNOM have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GNOM has higher volatility (7.69%) compared to SRVR (4.22%). In terms of maximum drawdown, SRVR dropped -40.99% vs GNOM's -75.00%.
On 5-year performance, SRVR leads with -3.67% vs -9.25% for GNOM. On fees, SRVR is cheaper at 0.49% per year. On volatility, SRVR has been the lower-risk option at 4.22%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SRVR has performed better with a -3.67% return vs -9.25%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SRVR is cheaper with a 0.49% expense ratio, compared with 0.50% for GNOM.
SRVR has the higher dividend yield at 2.86%, compared with 1.18% for GNOM.
SRVR is categorized as REIT, while GNOM is Health & Biotech Equities. SRVR tracks FTSE Nareit All Equity REITs Index, while GNOM tracks Solactive Genomics Index. They also come from different issuers: Pacer and Global X. Their fees differ too: 0.49% for SRVR and 0.50% for GNOM.
GNOM currently has the higher Sharpe Ratio (2.24 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SRVR and GNOM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer